In today's video, I discuss an artificial intelligence stock focused on agentic solutions, its business strategy, growth ...

UiPath's ARR to reach $1.816B in FY26 amid strong AI automation growth. Explore profitability, valuation, and challenges ...

US-based healthcare software provider Coronis Health has adopted the UiPath Platform from AI solution developer UiPath to ...

EverSource Wealth Advisors LLC raised its stake in UiPath Inc. (NYSE:PATH – Free Report) by 141.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional ...

Learn more about whether Elastic N.V. or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare ...

Learn more about whether CCC Intelligent Solutions Holdings Inc. or UiPath Inc. is a better investment based on AAII's A+ ...

Cathie Wood’s Ark Invest recently sold over 550,000 shares of UiPath (NYSE:PATH). The stock is down 16% so far this year.

Canadian investors could consider owning beaten-down AI stocks such as AMD to generate outsized gains in the next 12 months.

UiPath, a leading enterprise automation and AI software company, has announced its annual UiPath Agentic AI Summit will take ...

UiPath to hold Agentic AI Summit on March 25 to demonstrate its latest agentic automation innovations and how UiPath ...

In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...

UiPath (PATH) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...